SAEC Teams with HMOs on PGx Study | GenomeWeb

NEW YORK (GenomeWeb News) – The International Serious Adverse Events Consortium (SAEC) plans to collaborate with the HMO Research Network (HMORN), a consortium of 16 health plans with 14 million members, to determine the feasibility of using HMORN's clinical data warehouse to study drug-induced serious adverse events.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.